BioSpace News Archive

Drug Development

American Gene Technologies Gets Go-Ahead to Test Possible HIV Cure

American Gene Technologies (AGT), based in Rockville, Maryland, received the go-ahead from the U.S. Food and Drug Administration (FDA) to begin a Phase I clinical trial of AGT103-T, a gene therapy, to eliminate HIV from infected individuals.

August 13, 2020
·
4 min read
·
Mark Terry
Business

BioSpace Movers & Shakers, Aug. 14

Biopharma and life sciences companies bolster their executive ranks and boards with these Movers & Shakers.

August 13, 2020
·
5 min read
·
Alex Keown
Drug Development

Biopharma Update on the Novel Coronavirus: August 14

Please check out the biopharma industry coronavirus (COVID-19) stories that are trending for August 14, 2020.

August 13, 2020
·
3 min read
·
BioSpace Editorial Staff
Biotech Beach

Avellino Hits the 1-Million Genetic Test Milestone

Avellino announced that the company has performed over 1-million genetic and molecular diagnostic tests.

August 13, 2020
·
3 min read
Bio NC

RedHill Biopharma and Cosmo Pharmaceuticals to Expand Strategic Partnership with Exclusive Licensing Agreement and Manufacturing Agreement for Multiple Products

RedHill Biopharma Ltd., a specialty biopharmaceutical company, announced that it has entered into a binding term sheet with Cosmo Pharmaceuticals N.V. for an exclusive licensing and manufacturing agreement for multiple products.

August 13, 2020
·
11 min read
Business

METTLER TOLEDO and TetraScience Collaborate to Power the Digital Lab Movement

METTLER TOLEDO International Inc. and TetraScience, Inc. announce a new collaboration to knock down life sciences R&D data silos by providing complete and unified R&D data in the cloud.

August 13, 2020
·
3 min read
Business

TransEnterix Announces Appointment of Shameze Rampertab as Chief Financial Officer

TransEnterix, Inc., a medical device company that is digitizing the interface between the surgeon and the patient to improve minimally invasive surgery, announced that Shameze Rampertab has been appointed as the Company’s Executive Vice President and Chief Financial Officer, effective August 24, 2020.

August 13, 2020
·
4 min read
BioCapital

Cerecor Announces Peer-Reviewed Publication Highlighting the Role of the Inflammatory Cytokine, LIGHT, in COVID-19 ARDS

The data strongly support Cerecor’s ongoing clinical study of CERC-002 as a novel potential treatment for COVID-19-related ARDS

August 13, 2020
·
7 min read
Business

Precision BioSciences Reports Second Quarter 2020 Financial Results and Provides Business Update

Dosed First Patient in Phase 1/2a Clinical Trial of PBCAR269A, a BCMA-Targeted Allogeneic CAR T Candidate for Multiple Myeloma

August 13, 2020
·
13 min read
Deals

Organicell Completes Capital Raise from Retrograde Investments

Organicell Regenerative Medicine, Inc., a clinical-stage biopharmaceutical company dedicated to the development of regenerative therapies, announced that it has completed an initial capital raise from Retrograde Investments LLC.

August 13, 2020
·
3 min read